Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 536
Filtrar
1.
Cell Mol Biol (Noisy-le-grand) ; 70(4): 53-60, 2024 Apr 28.
Artículo en Inglés | MEDLINE | ID: mdl-38678627

RESUMEN

Cobalt protoporphyrin (CoPP) is a synthetic heme analog that has been observed to reduce food intake and promote sustained weight loss. While the precise mechanisms responsible for these effects remain elusive, earlier research has hinted at the potential involvement of nitric oxide synthase in the hypothalamus. This study aimed to delve into CoPP's impact on the activities of crucial antioxidant enzymes: superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione reductase (GR), and glutathione-S-transferase (GST) across seven distinct brain regions (hippocampus, hypothalamus, prefrontal cortex, motor cortex, striatum, midbrain, and cerebellum), as well as in the liver and kidneys. Female Wistar rats weighing 180 to 200 grams received a single subcutaneous dose of 25 µmol/kg CoPP. After six days, brain tissue was extracted to assess the activities of antioxidant enzymes and quantify malondialdehyde levels. Our findings confirm that CoPP administration triggers the characteristic effects of decreased food intake and reduced body weight. Moreover, it led to an increase in SOD activity in the hypothalamus, a pivotal brain region associated with food intake regulation. Notably, CoPP-treated rats exhibited elevated enzymatic activity of catalase, GR, and GST in the motor cortex without concurrent signs of heightened oxidative stress. These results underscore a strong connection between the antioxidant system and food intake regulation. They also emphasize the need for further investigation into the roles of antioxidant enzymes in modulating food intake and the ensuing weight loss, using CoPP as a valuable research tool.


Asunto(s)
Antioxidantes , Hipotálamo , Corteza Motora , Protoporfirinas , Animales , Femenino , Ratas , Antioxidantes/metabolismo , Peso Corporal/efectos de los fármacos , Catalasa/metabolismo , Ingestión de Alimentos/efectos de los fármacos , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/efectos de los fármacos , Glutatión Reductasa/metabolismo , Glutatión Transferasa/efectos de los fármacos , Glutatión Transferasa/metabolismo , Hipotálamo/metabolismo , Hipotálamo/efectos de los fármacos , Hipotálamo/enzimología , Malondialdehído/metabolismo , Corteza Motora/efectos de los fármacos , Corteza Motora/metabolismo , Corteza Motora/enzimología , Estrés Oxidativo/efectos de los fármacos , Protoporfirinas/farmacología , Ratas Wistar , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo
2.
Arthritis Res Ther ; 25(1): 66, 2023 04 22.
Artículo en Inglés | MEDLINE | ID: mdl-37087463

RESUMEN

BACKGROUND: Neutrophils have a critical role in the pathogenesis of rheumatoid arthritis (RA) with immune system dysfunction. However, the molecular mechanisms of this process mediated by neutrophils still remain elusive. The purpose of the present study is to identify hub genes in neutrophils for diagnosis and treatment of RA utilizing publicly available datasets. METHODS: Gene expression profiles were downloaded from the Gene Expression Omnibus, and batch-corrected and normalized expression data were obtained using the ComBat package. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis were used to conduct significantly functional analysis and crucial pathways. The resulting co-expression genes modules and hub genes were generated based on the weighted gene co-expression network analysis and visualization by Cytoscape. Flow cytometry was conducted to detect reactive oxygen species (ROS) levels in neutrophils. RESULTS: Neutrophils underwent transcriptional changes in synovial fluid (SF) of RA patients, different from peripheral blood of healthy controls or patients with RA. Especially, glycolysis, HIF-1 signaling, NADH metabolism, and oxidative stress were affected. These hub genes were strongly linked with classical glycolysis-related genes (ENO1, GAPDH, and PKM) responsible for ROS production. The antioxidant enzyme glutathione peroxidase 3 (GPX3), a ROS scavenger, was first identified as a hub gene in RA neutrophils. Neutrophils from patients with autoinflammatory and autoimmune diseases had markedly enhanced ROS levels, most notably in RA SF. CONCLUSION: This research recognized hub genes and explored the characteristics of neutrophils in RA. Our findings suggest that the novel hub gene GPX3 is involved in the neutrophil-driven oxidative stress-mediated pathogenesis of RA. It has the potency to be a target for neutrophil-directed RA therapy.


Asunto(s)
Artritis Reumatoide , Glutatión Peroxidasa , Neutrófilos , Humanos , Artritis Reumatoide/diagnóstico , Artritis Reumatoide/genética , Artritis Reumatoide/tratamiento farmacológico , Biomarcadores/metabolismo , Perfilación de la Expresión Génica/métodos , Glutatión Peroxidasa/química , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Especies Reactivas de Oxígeno/metabolismo
3.
Toxicology ; 468: 153103, 2022 02 28.
Artículo en Inglés | MEDLINE | ID: mdl-35090963

RESUMEN

Benzene can impair peripheral immunity and immune organs; however, the recovery of benzene impairment has rarely been reported. In this study, we developed an immune dysfunction mouse model using a benzene gavage (500 mg/kg). Female Balb/c mice were treated with Bombyx batryticatus (BB, 5 g/kg), raw pinellia (RP, 5 g/kg), or a combination of Valproic acid and Coenzyme Q10 (CM, 150 mg/kg VPA & 100 mg/kg CoQ10) medication for four weeks. The immune function of the peripheral blood mononuclear cells (PBMCs), spleen, and thymus was determined to evaluate whether the observed impairment could be altered by medications in the mouse model. Results showed that medications could alleviate benzene-induced structural and functional damage of spleen and thymus. Benzene exposure decreased the ATP level of PBMC, which can be improved by BB, RP or CM. Importantly, BB, RP or CM could relieve benzene induced-oxidative stress by increasing the activities of glutathione peroxidase (GSH) and superoxide dismutase (SOD) and decreasing the contents of malondialdehyde (MDA). In conclusion, BB, RP, and CM were able to alleviate the benzene-induced immune dysfunction and redox imbalance. Improvement of the oxidative and antioxidant imbalance may represent a mechanism by which medicine prevents benzene-induced immune dysfunction.


Asunto(s)
Benceno/toxicidad , Inmunidad/efectos de los fármacos , Leucocitos Mononucleares/efectos de los fármacos , Bazo/efectos de los fármacos , Timo/efectos de los fármacos , Adenosina Trifosfato/sangre , Animales , Bombyx/química , Femenino , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Leucocitos Mononucleares/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Pinellia/química , Extractos Vegetales/farmacología , Organismos Libres de Patógenos Específicos , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Ubiquinona/farmacología , Ácido Valproico/farmacología
4.
Physiol Rep ; 9(22): e15090, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34816616

RESUMEN

Pulmonary hypertension (PH) is a global health issue with a prevalence of 10% in ages >65 years. Right heart failure (RHF) is the main cause of death in PH. We have previously shown that monocrotaline (MCT)-induced PH and RHF are due to an increase in oxidative stress. In this study, probucol (PROB), a strong antioxidant with a lipid-lowering property, versus lovastatin (LOV), a strong lipid-lowering drug with some antioxidant effects, were evaluated for their effects on the MCT-induced RHF. Rats were treated (I.P.) with PROB (10 mg/kg ×12) or LOV (4 mg/kg ×12), daily 6 days before and 6 days after a single MCT injection (60 mg/kg). Serial echocardiography was performed and at 4-week post-MCT, lung wet-to-dry weight, hemodynamics, RV glutathione peroxidase (GSHPx), superoxide dismutase (SOD), catalase, lipid peroxidation, and myocardial as well as plasma lipids were examined. MCT increased RV systolic and diastolic pressures, wall thickness, RV end diastolic diameter, mortality, and decreased ejection fraction as well as pulmonary artery acceleration time. These changes were mitigated by PROB while LOV had no effect. Furthermore, PROB prevented lipid peroxidation, lowered lipids, and increased GSHPx and SOD in RV myocardium. LOV did decrease the lipids but had no effect on antioxidants and lipid peroxidation. A reduction in oxidative stress and not the lipid-lowering effect of PROB may explain the prevention of MCT-induced PH, RHF, and mortality. Thus targeting of oxidative stress as an adjuvant therapy is suggested.


Asunto(s)
Anticolesterolemiantes/farmacología , Antioxidantes/farmacología , Insuficiencia Cardíaca/metabolismo , Corazón/efectos de los fármacos , Hipertensión Pulmonar/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Lovastatina/farmacología , Miocardio/metabolismo , Estrés Oxidativo/efectos de los fármacos , Probucol/farmacología , Animales , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Ecocardiografía , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Insuficiencia Cardíaca/inducido químicamente , Insuficiencia Cardíaca/tratamiento farmacológico , Insuficiencia Cardíaca/fisiopatología , Hemodinámica , Hipertensión Pulmonar/inducido químicamente , Hipertensión Pulmonar/tratamiento farmacológico , Hipertensión Pulmonar/fisiopatología , Pulmón/efectos de los fármacos , Monocrotalina/toxicidad , Tamaño de los Órganos/efectos de los fármacos , Ratas , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Disfunción Ventricular Derecha/inducido químicamente , Disfunción Ventricular Derecha/tratamiento farmacológico , Disfunción Ventricular Derecha/metabolismo , Disfunción Ventricular Derecha/fisiopatología
5.
Pak J Pharm Sci ; 34(3): 861-867, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-34602407

RESUMEN

This experiment proposed to study the efficiency omega 3 fatty acid on behavioural phenotype of Parkinson's disease (PD) in mice. Totally 7 groups (each group 6 mice) were used in this assessment, each groups were treated with saline (control), MPP+, L-DOPA, Omega 3 oil, Omega 3 oil (three different concentrations) +MPP+ separately. The behavioral assessments such as bar test, open field test, maze test, hang test were noted on 7th, 14th, 21st and 28th day. After the examination period, the tested animals' midbrains and frontal cortex were dissected to analyze TBARS, GSH, Catalase, Superoxide Dismutase and Glutathione Peroxidase assay. In the bar test, 500mg omega 3 fatty acid administrated mice showed a high cataleptic scores. In open field Test, significant reductions in behavior analysis were observed from the tested mice group. Maze test and hang test doesn't show much difference. In biochemical test, tested groups showed promising results compared to control group. The result strongly proved that the omega 3 fatty acid has remarkable abilities to control the neurodegenerative diseases.


Asunto(s)
Antiparkinsonianos/farmacología , Conducta Animal/efectos de los fármacos , Ácidos Grasos Omega-3/farmacología , Estrés Oxidativo/efectos de los fármacos , Trastornos Parkinsonianos/fisiopatología , 1-Metil-4-fenilpiridinio/toxicidad , Animales , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Reacción Cataléptica de Congelación , Lóbulo Frontal/efectos de los fármacos , Lóbulo Frontal/metabolismo , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Levodopa/farmacología , Masculino , Mesencéfalo/efectos de los fármacos , Mesencéfalo/metabolismo , Ratones , Prueba de Campo Abierto , Trastornos Parkinsonianos/inducido químicamente , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
6.
J Ocul Pharmacol Ther ; 37(9): 518-524, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34558962

RESUMEN

Purpose: To measure the serum levels of the oxidative stress markers superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione peroxidase (GPx) and compare them before and after zinc supplementation in patients with early age-related macular degeneration (AMD). Methods: We measured serum zinc levels in 65 patients with early AMD. Of these, 29 patients with macular drusen and a serum zinc level <80 µg/dL received oral zinc acetate dihydrate (50 mg/day). Serum trace metal levels (zinc and copper) and oxidative stress marker levels (SOD, MDA, and GPx) were measured at baseline and 12 weeks after the treatment. The macular drusen areas and best-corrected visual acuity were evaluated in 24 participants who attended the 3-month follow-up. Results: MDA level was significantly decreased from baseline to 12 weeks after zinc administration (170.5 ± 100.9 vs. 148.3 ± 57.9 pmol/mL, P = 0.03), while SOD was significantly increased from baseline to 12 weeks after zinc intake (4.2 ± 0.9 vs. 4.6 ± 0.9 U/mL, P = 0.03). The serum zinc level was significantly correlated with the MDA level (P = 0.03, ρ = -0.26). The area of soft drusen was significantly decreased after zinc treatment (1,936,654.9 ± 1,348,267.6 vs. 966,883.9 ± 719,938.1 µmm2, P = 0.04). Conclusions: The levels of oxidative stress markers MDA and SOD decreased and increased, respectively, after oral zinc administration to 24 patients with AMD. The therapeutic effect of zinc treatment on drusen area might differ depending on the drusen phenotype in early AMD.


Asunto(s)
Degeneración Macular/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Acetato de Zinc/uso terapéutico , Anciano , Biomarcadores , Cobre/administración & dosificación , Cobre/sangre , Quimioterapia Combinada , Femenino , Glutatión Peroxidasa/efectos de los fármacos , Humanos , Masculino , Malondialdehído/metabolismo , Persona de Mediana Edad , Drusas del Disco Óptico/patología , Estudios Prospectivos , Superóxido Dismutasa/efectos de los fármacos , Agudeza Visual , Zinc/administración & dosificación , Zinc/sangre
7.
Pak J Pharm Sci ; 34(1(Special)): 373-379, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34275782

RESUMEN

Fluorine toxicity has negative effects on soft tissue besides skeletal and dental tissues. In the present study, we have investigated the protective effect of chitosan (CS) and chitosan oligosaccharide (COS) on liver tissue of fluorine-intoxicated rats taking the antioxidant characteristics of chitosan and its derivatives into consideration. In this study, 42 male Wistar albino rats were randomly selected to determine the control and experimental fluorosis groups. Our study lasted for 12 weeks. As a consequence of the study, MDA significantly increased in the liver tissue of NaF group while some antioxidant values significantly decreased. It was detected that serum AST and LDH levels increased significantly while ALB and TP values significantly decreased in NaF group. The degenerations were identified in the liver histopathology of all fluoride-treated groups. We have concluded according to the results that chitosan oligosaccharide can be more effective compared with chitosan.


Asunto(s)
Antioxidantes/farmacología , Quitosano/farmacología , Hígado/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Fluoruro de Sodio/toxicidad , Animales , Aspartato Aminotransferasas/efectos de los fármacos , Aspartato Aminotransferasas/metabolismo , Proteínas Sanguíneas/efectos de los fármacos , Proteínas Sanguíneas/metabolismo , Quitosano/análogos & derivados , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , L-Lactato Deshidrogenasa/efectos de los fármacos , L-Lactato Deshidrogenasa/metabolismo , Hígado/metabolismo , Hígado/patología , Masculino , Malondialdehído/metabolismo , Oligosacáridos/farmacología , Ratas , Ratas Wistar , Albúmina Sérica/efectos de los fármacos , Albúmina Sérica/metabolismo , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo
8.
Pak J Pharm Sci ; 34(1(Supplementary)): 265-274, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34275850

RESUMEN

Natural Plants are broadly used in treating inflammatory disorders. The current study focused on evaluating the hepato-protective and anti-inflammatory potential of A. modesta in MnCL2 induced hepatotoxicity and liver inflammation. The MnCl2 induce 6.0mg/kg was given for 30 days (p.o) to induced hepatotoxicity and liver inflammation. The ethanolic extract of A. modesta were given orally at the dose of 100mg/kg/day. The in vivo inflammatory manganese induced hepatotoxic model is used for evaluating the acacia heap to-protective effect. Gas chromatography-mass spectrometry analyses were performed to find out compounds responsible for anti-inflammatory properties. Results showed that administration of ethanolic extract (100 mg/kg), altogether diminished inflammation of the liver, expanded liver capacity, oxidative stress and his to-pathological outcomes in the current study compared with disease rats. The beneficial outcomes of A. modesta extract were observed on liver inflammation.


Asunto(s)
Acacia , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Cloruros/toxicidad , Inflamación/metabolismo , Hígado/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Interleucina-18/genética , Interleucina-4/genética , Hígado/metabolismo , Hígado/patología , Compuestos de Manganeso , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Factor de Necrosis Tumoral alfa/efectos de los fármacos , Factor de Necrosis Tumoral alfa/genética
9.
Pharmacology ; 106(9-10): 564-572, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34182567

RESUMEN

INTRODUCTION: Recent studies highlighted the association of hyperuricemia and metabolic syndrome (MS). The aim of this study was to compare the beneficial effects of febuxostat versus allopurinol on the biochemical changes that occur in MS. METHODS: Forty adult male Sprague Dawley albino rats were used in the study. Insulin resistance and MS were induced by administration of a high-fructose diet for 8 weeks. Follow-up of changes in weight, blood pressure, serum biochemical parameters, serum antioxidant catalase, and glutathione peroxidase activities was done. At the end of the study, animals were sacrificed, and the thoracic aorta was isolated for in vitro study of the endothelial integrity. RESULTS: Allopurinol and febuxostat treatment induced significant reduction in body weight, systolic blood pressure, blood glucose, insulin, lipids, and improved kidney functions and endothelial integrity compared to nontreated rats. Febuxostat was more effective than allopurinol in normalizing serum fasting glucose, uric acid, catalase, and glutathione peroxidase activities. CONCLUSION: Xanthine oxidase inhibitors ameliorated the effects of MS. Febuxostat was mildly superior to allopurinol in lowering serum fasting glucose, lipids, uric acid, and antioxidant enzyme activities.


Asunto(s)
Alopurinol/farmacología , Febuxostat/farmacología , Síndrome Metabólico/tratamiento farmacológico , Xantina Oxidasa/antagonistas & inhibidores , Animales , Glucemia/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Catalasa/efectos de los fármacos , Modelos Animales de Enfermedad , Glutatión Peroxidasa/efectos de los fármacos , Resistencia a la Insulina , Masculino , Ratas , Ratas Sprague-Dawley
10.
Aging (Albany NY) ; 13(4): 5020-5033, 2021 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-33534781

RESUMEN

Titanium dioxide nanoparticles (TiO2 NPs) are widely used in a variety of areas. However, TiO2 NPs possess cytotoxicity which involves oxidative stress. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key molecule preventing cells from oxidative stress damage. In the current study, we explored the effect of Nrf2 signaling pathway in TiO2 NPs-induced corneal endothelial cell injury. Firstly, we found TiO2 NPs inhibited proliferation and damaged morphology and mitochondria of mouse primary corneal endothelial cells. Moreover, TiO2 NPs-induced oxidative damage of mouse primary corneal endothelial cells was inhibited by antioxidant NAC by evaluating production of reactive oxygen species (ROS), malondialdehyde (MDA), and activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px). Next, flow cytometry analysis showed TiO2 NPs promoted apoptosis and cell cycle G2/M phase arrest of mouse primary corneal endothelial cells. Further investigation suggested that Nrf2 signaling pathway activation and the downregulation of ZO-1, ß-catenin and Na-K-ATPase were involved in TiO2 NPs-induced mouse primary corneal endothelial cell injury. Our research highlighted the toxic effect of TiO2 NPs on corneas in vitro and in vivo, providing an alternative insight into TiO2 NPs-induced corneal endothelial cell injury.


Asunto(s)
Córnea/efectos de los fármacos , Células Endoteliales/efectos de los fármacos , Nanopartículas del Metal/toxicidad , Factor 2 Relacionado con NF-E2/efectos de los fármacos , Titanio/toxicidad , Acetilcisteína/farmacología , Animales , Antioxidantes/farmacología , Proliferación Celular/efectos de los fármacos , Córnea/metabolismo , Células Endoteliales/metabolismo , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Técnicas In Vitro , Malondialdehído/metabolismo , Ratones , Mitocondrias/efectos de los fármacos , Factor 2 Relacionado con NF-E2/metabolismo , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo
11.
Nutrients ; 13(2)2021 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-33572579

RESUMEN

We examined, in a rat model of moderate environmental human exposure to cadmium (Cd), whether the enhanced intake of zinc (Zn) may protect against Cd-caused destroying the oxidative/antioxidative balance and its consequences in the brain. The intoxication with Cd (5 mg/L, 6 months) weakened the enzymatic (superoxide dismutase, glutathione peroxidase, catalase) and non-enzymatic (total thiol groups, reduced glutathione) antioxidative barrier decreasing the total antioxidative status and increased the concentrations of pro-oxidants (hydrogen peroxide, myeloperoxidase) in this organ and its total oxidative status. These resulted in the development of oxidative stress and oxidative modifications of lipids and proteins. The co-administration of Zn (30 and 60 mg/L enhancing this element intake by 79% and 151%, respectively) importantly protected against Cd accumulation in the brain tissue and this xenobiotic-induced development of oxidative stress and oxidative damage to lipids and proteins. Moreover, this bioelement also prevented Cd-mediated oxidative stress evaluated in the serum. The favorable effect of Zn was caused by its independent action and interaction with Cd. Concluding, the enhancement of Zn intake under oral exposure to Cd may prevent the oxidative/antioxidative imbalance and oxidative stress in the brain and thus protect against injury of cellular macromolecules in the nervous system.


Asunto(s)
Encéfalo/metabolismo , Cadmio/metabolismo , Exposición a Riesgos Ambientales/efectos adversos , Estrés Oxidativo/efectos de los fármacos , Oligoelementos/administración & dosificación , Zinc/administración & dosificación , Animales , Encéfalo/efectos de los fármacos , Cadmio/administración & dosificación , Cadmio/toxicidad , Intoxicación por Cadmio/complicaciones , Intoxicación por Cadmio/metabolismo , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Agua Potable , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Peróxido de Hidrógeno/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , Modelos Animales , Oxidación-Reducción , Estrés Oxidativo/fisiología , Peroxidasa/metabolismo , Proteínas/metabolismo , Ratas , Ratas Wistar , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Factores de Tiempo , Oligoelementos/metabolismo , Oligoelementos/farmacología , Zinc/metabolismo , Zinc/farmacología
12.
Biomed Pharmacother ; 137: 111345, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-33556873

RESUMEN

The aim of this work was to evaluate the gastroprotective activity of a Mexican propolis on indomethacin-induced gastric ulcers in a mouse model. The following contents of the ethanolic extract of propolis of Chihuahua (EEPCh) were determined: antioxidant activity (SA50), total phenolic content (TPC), total flavonoid content (TFC), and chemical composition by HPLC-DAD and HPLC-MS, as well as acute toxicity by OECD Guideline 423. Gastric lesions were induced by intragastric indomethacin treatment in male ICR mice. As the positive control, omeprazole was administered, and three doses of EEPCh were evaluated (50, 150 and 300 mg/kg). Gastric mucosal injury, histological changes and mucosal content were evaluated by means of H&E and PAS staining. For homogenized gastric tissues, the following were evaluated: TBARS, MPO, and PGE2 levels; SOD and GPx antioxidant enzymatic activity; and the concentrations of the proinflammatory cytokines, TNF-α, IL-1ß and IL-6. EEPCh had a significant SA50 of 41.55 µg/mL. The TPC of EEPCh was 860 mg GAE/g, and its TFC was 49.58 mg QE/g. Different phenolic compounds were identified in the extract and were not toxic. The EEPCh doses decreased mucosal damage and histological injuries, maintained the mucosal content and reduced the TBARS, MPO and concentrations of proinflammatory cytokines in gastric ulcer tissues. The 150 and 300 mg/kg doses increased the SOD activity and maintained the PGE2 content. Only the 300 mg/kg dose increased the GPx activity. The results of this study suggest that EEPCh displays gastroprotective effects by means of its antioxidant activity and anti-inflammatory effects and promotes ulcer protection through the maintenance of mucosal content and PGE2 levels.


Asunto(s)
Antiulcerosos/química , Antiulcerosos/farmacología , Extractos Vegetales/química , Extractos Vegetales/farmacología , Própolis/química , Própolis/farmacología , Úlcera Gástrica/prevención & control , Animales , Antiulcerosos/uso terapéutico , Antioxidantes/análisis , Citocinas/metabolismo , Dinoprostona/metabolismo , Modelos Animales de Enfermedad , Femenino , Flavonoides/análisis , Flavonoides/química , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/lesiones , Mucosa Gástrica/patología , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Indometacina/toxicidad , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Ratones Endogámicos ICR , Omeprazol/farmacología , Fenoles/análisis , Fenoles/química , Extractos Vegetales/uso terapéutico , Própolis/uso terapéutico , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/patología , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo
13.
Asian J Androl ; 23(2): 215-221, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32394901

RESUMEN

Penile length shortening and erectile dysfunction are common complications after radical prostatectomy. Various methods have been used to maintain erectile function, but less attention has been paid to preserving penis length. N-acetylcysteine (NAC) has the effect of antioxidation and antifibrotic, which may be beneficial to improve those postoperative complications. This study investigated the effect of NAC on maintaining the penile length and the erectile function after bilateral cavernous nerve crush (BCNC) and its underlying mechanism. Twenty-four male rats were randomly divided into three groups: control group, BCNC group, and BCNC + NAC group. NAC or equal volume of saline was daily administrated by intragastric gavage for 4 weeks. The initial and end penile lengths were measured. Intracavernosal pressure/mean arterial pressure (ICP/MAP) ratio was calculated to assess erectile function. Hematoxylin-eosin staining, Masson's trichrome staining, immunohistochemistry, and Western blot were performed to explore cellular and molecular changes of the penis. Compared to the BCNC group, the penile length, ICP/MAP ratio and smooth muscle/collagen ratio in the BCNC + NAC group were improved significantly (all P < 0.05), and the expressions of endothelial nitric oxide synthase, α-smooth muscle actin, glutathione, and glutathione peroxidase 1 were significantly increased after NAC treated (all P < 0.05), along with the decreased expressions of hypoxia-inducible factor-1α, transforming growth factor-ß1, collagen I, collagen III, collagen IV, malonaldehyde, and lysine oxidase (all P < 0.05). This study demonstrated that NAC could maintain penile length and partly improve erectile function. Possible mechanism is directly and/or indirectly related to antihypoxic and antifibrosis.


Asunto(s)
Acetilcisteína/farmacología , Lesiones por Aplastamiento/metabolismo , Depuradores de Radicales Libres/farmacología , Erección Peniana/efectos de los fármacos , Pene/efectos de los fármacos , Traumatismos de los Nervios Periféricos/metabolismo , Actinas/efectos de los fármacos , Actinas/metabolismo , Animales , Colágeno/efectos de los fármacos , Colágeno/metabolismo , Lesiones por Aplastamiento/patología , Lesiones por Aplastamiento/fisiopatología , Modelos Animales de Enfermedad , Disfunción Eréctil/prevención & control , Fibrosis , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Subunidad alfa del Factor 1 Inducible por Hipoxia/efectos de los fármacos , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Masculino , Malondialdehído/metabolismo , Óxido Nítrico Sintasa de Tipo III/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo III/metabolismo , Tamaño de los Órganos , Pene/inervación , Pene/patología , Traumatismos de los Nervios Periféricos/patología , Traumatismos de los Nervios Periféricos/fisiopatología , Complicaciones Posoperatorias/prevención & control , Prostatectomía , Neoplasias de la Próstata/cirugía , Proteína-Lisina 6-Oxidasa/efectos de los fármacos , Proteína-Lisina 6-Oxidasa/metabolismo , Ratas , Factor de Crecimiento Transformador beta1/efectos de los fármacos , Factor de Crecimiento Transformador beta1/metabolismo , Glutatión Peroxidasa GPX1
14.
Aging (Albany NY) ; 13(2): 2727-2749, 2020 12 29.
Artículo en Inglés | MEDLINE | ID: mdl-33373318

RESUMEN

Oxybenzone (OBZ), an ultraviolet light filter that is widely used in sunscreens and cosmetics, is an emerging contaminant found in humans and the environment. Recent studies have shown that OBZ has been detected in women's plasma, urine, and breast milk. However, the effects of OBZ exposure on oocyte meiosis have not been addressed. In this study, we investigated the detrimental effects of OBZ on oocyte maturation and the protective roles of melatonin (MT) in OBZ-exposed mouse models. Our in vitro and in vivo results showed that OBZ suppressed oocyte maturation, while MT attenuated the meiotic defects induced by OBZ. In addition, OBZ facilitated H3K4 demethylation by increasing the expression of the Kdm5 family of genes, elevating ROS levels, decreasing GSH, impairing mitochondrial quality, and disrupting spindle configuration in oocytes. However, MT treatment resulted in significant protection against OBZ-induced damage during oocyte maturation and improved oocyte quality. The mechanisms underlying the beneficial roles of MT involved reduction of oxidative stress, inhibition of apoptosis, restoration of abnormal spindle assembly and up-regulation of H3K4me3. Collectively, our results suggest that MT protects against defects induced by OBZ during mouse oocyte maturation in vitro and in vivo.


Asunto(s)
Antioxidantes/farmacología , Benzofenonas/toxicidad , Meiosis/efectos de los fármacos , Melatonina/farmacología , Oocitos/efectos de los fármacos , Oogénesis/efectos de los fármacos , Protectores Solares/toxicidad , Animales , Apoptosis/efectos de los fármacos , Apoptosis/genética , Desmetilación , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/genética , Histona Demetilasas/efectos de los fármacos , Histona Demetilasas/genética , Histonas/efectos de los fármacos , Histonas/metabolismo , Técnicas In Vitro , Ratones , Oogénesis/genética , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Huso Acromático/efectos de los fármacos
15.
Int. j. morphol ; 38(6): 1786-1796, Dec. 2020. graf
Artículo en Inglés | LILACS | ID: biblio-1134512

RESUMEN

SUMMARY: Bisphenol A (BPA) is an industrial chemical widely used to make polycarbonate plastics for packaging and epoxy resins. This study sought to examine how selenium (Se) affects BPA toxicity in terms of albino rats' histological structure, antioxidant enzymes and reproductive organs (seminiferous tubules). Twenty-four adult male rats were divided into four experimental groups: Group 1: Control; Group 2: Orally administered BPA; Group 3: Orally administered sodium selenite; Group 4: Treated daily with BPA followed by selenium (Se). All experiment done for 4 weeks. BPA exposure caused changes in the testicular histological structure, which consists apoptosis, and led to changes in several biochemical markers: Malondialdehyde, catalase, superoxide dismutase, and glutathione peroxidase. However, these BPA side effects may be ameliorated in rats treated with BPA-plus-Se. These protective effects of Se may attributable to its ability to remove potentially damaging oxidizing agents in living organisms. The results may confirm that Se countered the oxidant effects and increased the BPA-induced stress response in rats. So, Se promotes the healthy growth and development of mammals by protecting them from oxidative stress. As human are greatly exposed to BPA and it can accumulate in tissues, there is concern about human reproductive functions particularly for occupational workers exposed usually to greater levels of BPA. Thus, the use of BPA in multiple industries must be restricted and the inaccurate usage of plastic containers should be avoided to decrease the health hazards. Administration of Se may protect against the adverse effects of BPA on reproductive functions and structures.


RESUMEN: El bisfenol A (BPA) es un químico industrial ampliamente utilizado para fabricar plásticos de policarbonato para envases y resinas epoxi. Este estudio examinó el efecto de selenio (Se) en la toxicidad del BPA en términos de la estructura histológica, enzimas antioxidantes y los órganos reproductivos (túbulos seminíferos) de ratas albinas. Se dividieron veinticuatro ratas macho adultas en cuatro grupos experimentales: Grupo 1: control; Grupo 2: BPA administrado por vía oral; Grupo 3: BPA administrado por vía oral para; Grupo 4: tratado diariamente con BPA seguido de selenio (Se). El experimento se realizó durante cuatro semanas y se observó que la exposición al BPA provocó cambios en la estructura histológica testicular, incluyendo apoptosis, y alteraciones en varios marcadores bioquímicos:malondialdehído, catalasa, superóxido dismutasa y glutatión peroxidasa. Sin embargo, estos efectos secundarios del BPA pueden mejorar en ratas tratadas con BPA-plus-Se. Estos efectos protectores del Se pueden ser atribuidos a la capacidad de eliminar agentes oxidantes potencialmente dañinos en organismos vivos. Los resultados indicaron que se contrarrestaron los efectos oxidantes y aumentó la respuesta al estrés inducido por BPA en ratas, y favorece el crecimiento y desarrollo en los mamíferos al protegerlos del estrés oxidativo. Debido a la exposición al BPA en el ser humano, se puede acumular en los tejidos, por lo que existe una preocupación por el daño a las funciones reproductivas en particular de los trabajadores que generalmente están expuestos a niveles más altos de BPA. Por lo tanto, se debe restringir el uso de BPA en las industrias y evitar el uso incorrecto de envases de plástico para así disminuir los riesgos para la salud. La administración correcta de Se puede proteger contra los efectos adversos del BPA en las funciones y estructuras reproductivas.


Asunto(s)
Animales , Masculino , Ratas , Fenoles/toxicidad , Selenio/farmacología , Testículo/efectos de los fármacos , Compuestos de Bencidrilo/toxicidad , Antioxidantes/farmacología , Fenoles/administración & dosificación , Superóxido Dismutasa/efectos de los fármacos , Testículo/patología , Compuestos de Bencidrilo/administración & dosificación , Microscopía Electrónica , Biomarcadores , Catalasa/efectos de los fármacos , Administración Oral , Apoptosis/efectos de los fármacos , Estrés Oxidativo , Glutatión Peroxidasa/efectos de los fármacos
16.
Nutrients ; 12(9)2020 Aug 24.
Artículo en Inglés | MEDLINE | ID: mdl-32846876

RESUMEN

Fenugreek seeds are widely used in Asia and other places of the world for their nutritive and medicinal properties. In Asia, fenugreek seeds are also recommended for geriatric populations. Here, we evaluated for the first time the effect of fenugreek seed feed supplementation on the liver antioxidant defense systems in aging mice. The study was conducted on 12-months aged mice which were given fenugreek seed dietary supplement. We evaluated the activities of various antioxidant defense enzymes such as superoxide dismutase (SOD), glutathione reductase (GR), and glutathione peroxidase (GPx), and also estimated the phenolics and free radical scavenging properties in mice liver upon fenugreek supplementation. The estimation of SOD, GPx, and GR activities in aged mice liver revealed a significant (p < 0.01) difference among all the liver enzymes. Overall, this study reveals that fenugreek seed dietary supplementation has a positive effect on the activities of the hepatic antioxidant defense enzymes in the aged mice.


Asunto(s)
Antioxidantes/farmacología , Hígado/efectos de los fármacos , Hígado/metabolismo , Extractos Vegetales/farmacología , Envejecimiento , Animales , Suplementos Dietéticos , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/efectos de los fármacos , Glutatión Reductasa/metabolismo , Masculino , Ratones , Modelos Animales , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Trigonella
17.
J Diabetes Res ; 2020: 6762709, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32626781

RESUMEN

Diabetes mellitus (DM) is a chronic endocrine disease characterized by persistent hyperglycemia. Oxidative damage, inflammatory cytokines, and apoptotic cell death play a major role in the induction and progression of male testicular damage. Plant-derived phytochemicals such as green coffee (Coffea arabica) can possess antidiabetic effects with little toxicity. The current study is aimed at investigating the therapeutic roles of green coffee in diabetic testicular injury stimulated by high-fat diet/streptozotocin administration. Diabetes mellitus was induced by a high-fat diet and a single dose of streptozotocin (STZ) (35 mg kg-1) in male albino rats. Diabetic animals were orally given two different concentrations of green coffee (50 mg kg-1 and 100 mg kg-1) for 28 days. The levels of testosterone, luteinizing hormone, and follicle-stimulating hormone and parameters of oxidative stress, inflammation, and apoptosis were measured. mRNAs and protein levels were detected quantitatively by real-time PCR and ELISA, respectively. In the diabetic group, the levels of testosterone, luteinizing hormone, and follicle-stimulating hormone showed a significant reduction while they increased significantly after green coffee treatment. A significant increase of antioxidant markers glutathione, superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase along with decreased levels of lipid peroxides and nitric oxide was observed after green coffee treatment in the diabetic group. Finally, the levels of IL-1ß, TNF-α, Bax, and caspase-3 were also decreased in both treated groups (metformin and green coffee) when compared to the diabetic group. We conclude that testicular oxidative impairment induced by a high-fat diet (HFD) and STZ can be reversed by green coffee. Administration of green coffee could represent a promising therapeutic agent which can help the treatment of type 2 DM-induced testicular dysfunction.


Asunto(s)
Apoptosis/efectos de los fármacos , Coffea , Complicaciones de la Diabetes/metabolismo , Diabetes Mellitus Experimental/metabolismo , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Enfermedades Testiculares/metabolismo , Testículo/efectos de los fármacos , Animales , Caspasa 3/efectos de los fármacos , Caspasa 3/metabolismo , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Dieta Alta en Grasa , Ensayo de Inmunoadsorción Enzimática , Hormona Folículo Estimulante/metabolismo , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/efectos de los fármacos , Glutatión Reductasa/metabolismo , Hipoglucemiantes/farmacología , Inflamación/metabolismo , Interleucina-1beta/efectos de los fármacos , Interleucina-1beta/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Hormona Luteinizante/efectos de los fármacos , Hormona Luteinizante/metabolismo , Masculino , Metformina/farmacología , Óxido Nítrico/metabolismo , ARN Mensajero , Ratas , Reacción en Cadena en Tiempo Real de la Polimerasa , Estreptozocina/toxicidad , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Testículo/metabolismo , Testosterona/metabolismo , Factor de Necrosis Tumoral alfa/efectos de los fármacos , Factor de Necrosis Tumoral alfa/metabolismo , Proteína X Asociada a bcl-2/efectos de los fármacos , Proteína X Asociada a bcl-2/metabolismo
18.
Drug Deliv ; 27(1): 938-952, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32611270

RESUMEN

The present study sought to investigate the effect of non-mitogenic acidic fibroblast growth factor (NM-aFGF) loaded PEGylated nanoliposomes (NM-aFGF-PEG-lips) combined with the ultrasound-targeted microbubble destruction (UTMD) technique on modulating diabetic cardiomyopathy (DCM)and the mechanism involved. Animal studies showed that the diabetes mellitus (DM) group exhibited typical myocardial structural and functional changes of DCM. The indexes from the transthoracic echocardiography showed that the left ventricular function in the NM-aFGF-PEG-lips + UTMD group was significantly improved compared with the DM group. Histopathological observation further confirmed that the cardiomyocyte structural abnormalities and mitochondria ultrastructural changes were also significantly improved in the NM-aFGF-PEG-lips + UTMD group compared with DM group. The cardiac volume fraction (CVF) and apoptosis index in the NM-aFGF-PEG-lips + UTMD group decreased to 10.31 ± 0.76% and 2.16 ± 0.34, respectively, compared with those in the DM group (CVF = 21.4 ± 2.32, apoptosis index = 11.51 ± 1.24%). Moreover, we also found significantly increased superoxide dismutase (SOD) activity and glutathione peroxidase (GSH-Px) activity as well as clearly decreased lipid hydroperoxide levels and malondialdehyde (MDA) activity in the NM-aFGF-PEG-lips + UTMD group compared with those in the DM group (p < .05). Western blot analysis further revealed the highest level of NM-aFGF, p-AKT, p-GSK-3ß1, Nrf-2, SOD2 and NQO1 in the NM-aFGF-PEG-lips + UTMD group. This study confirmed using PEGylated nanoliposomes combined with the UTMD technique can effectively deliver NM-aFGF to the cardiac tissue of diabetic rats. The NM-aFGF can then inhibit myocardial oxidative stress damage due to DM by activating the AKT/GSK/Nrf-2 signaling pathway, which ultimately improved the myocardial structural and functional lesions in diabetic rats.


Asunto(s)
Cardiomiopatías Diabéticas/tratamiento farmacológico , Factor 1 de Crecimiento de Fibroblastos/administración & dosificación , Liposomas/química , Nanopartículas/química , Estrés Oxidativo/efectos de los fármacos , Ultrasonido/métodos , Animales , Química Farmacéutica/métodos , Glutatión Peroxidasa/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Microburbujas , Polietilenglicoles/química , Ratas , Ratas Sprague-Dawley , Superóxido Dismutasa/efectos de los fármacos
19.
Mol Neurobiol ; 57(8): 3273-3290, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32514861

RESUMEN

Probucol, a hypocholesterolemic compound, is neuroprotective in several models of neurodegenerative diseases but has serious adverse effects in vivo. We now describe the design and synthesis of two new probucol analogues that protect against glutamate-induced oxidative cell death, also known as ferroptosis, in cultured mouse hippocampal (HT22) cells and in primary cortical neurons, while probucol did not show any protective effect. Treatment with both compounds did not affect glutathione depletion but still significantly decreased glutamate-induced production of oxidants, mitochondrial superoxide generation, and mitochondrial hyperpolarization in HT22 cells. Both compounds increase glutathione peroxidase (GPx) 1 levels and GPx activity, also exhibiting protection against RSL3, a GPx4 inactivator. These two compounds are therefore potent activators of GPx activity making further studies of their neuroprotective activity in vivo worthwhile.


Asunto(s)
Ferroptosis/efectos de los fármacos , Glutatión Peroxidasa/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Probucol/farmacología , Animales , Antioxidantes/metabolismo , Muerte Celular/efectos de los fármacos , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Ratones , Mitocondrias/metabolismo , Neuroprotección/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo
20.
Mol Neurobiol ; 57(8): 3245-3257, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32506382

RESUMEN

Experimental evidence has shown that probucol, a hypocholesterolemic agent, is also able to increase glutathione peroxidase (GPx) activity. However, there is a lack of knowledge about the mechanism(s) involved in this event. In this study, in vitro experiments with purified GPx1 from bovine erythrocytes and cultured SH-SY5Y neuroblastoma cells, as well as in silico studies with GPx1, were performed in order to elucidate mechanisms mediating the stimulatory effect of probucol on GPx activity and to investigate the relevance of this event in terms of susceptibility against peroxide-induced cytotoxicity. In vitro experiments with purified GPx1 showed a direct stimulatory effect of probucol on the activity of GPx1, which was related to an increase in Vmax with no changes in KM. Probucol also increased GPx activity in cultured SH-SY5Y neuroblastoma cells, while the levels of GPx1 expression were not changed, corroborating the results found with the purified enzyme. In addition, probucol rendered SH-SY5Y cells more resistant to hydroperoxide-induced cytotoxicity, and this event was abolished in GPx1 knocked-down cells. In silico studies with GPx1 pointed to a potential binding site for probucol at the close vicinity of the GSH pocket. Collectively, the results presented herein indicate that GPx1 plays a central role in the probucol-induced protective effects against peroxide toxicity. This highlights a novel target (GPx1) and a new mechanism of action (direct activation) for an "old drug." The relevance of such results for in vivo conditions deserves further investigation.


Asunto(s)
Glutatión Peroxidasa/efectos de los fármacos , Neuronas/efectos de los fármacos , Probucol/farmacología , Sustancias Protectoras/farmacología , Glutatión Peroxidasa/metabolismo , Humanos , Peróxido de Hidrógeno/farmacología , Neuronas/metabolismo , Peróxidos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA